Modified VEGF oligonucleotides for treatment of skin disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 23, 2001
Issued Date -
N/A
app pub date -
Dec 6, 1996
filing date -
Dec 8, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed are oligonucleotides complementary to VEGF-specific nucleic acid useful in reducing the expression of VEGF. Also disclosed are pharmaceutical formulations containing such oligonucleotides useful for treating various disorders associated with neovascularization and angiogenesis, and methods for treating psoriasis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully